320 related articles for article (PubMed ID: 9209327)
1. Pathogenesis of Friend leukemia virus.
Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():152-4. PubMed ID: 9209327
[TBL] [Abstract][Full Text] [Related]
2. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
Yamamura Y; Senda H; Noda M; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
[TBL] [Abstract][Full Text] [Related]
3. Erythroleukaemia induction by the Friend spleen focus-forming virus.
Ruscetti SK
Baillieres Clin Haematol; 1995 Mar; 8(1):225-47. PubMed ID: 7663048
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation.
Rulli K; Yugawa T; Hanson C; Thompson D; Ruscetti S; Nishigaki K
J Virol; 2004 May; 78(9):4573-81. PubMed ID: 15078939
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
[TBL] [Abstract][Full Text] [Related]
6. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
[TBL] [Abstract][Full Text] [Related]
7. Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55).
Watanabe N; Yugawa T; Ikawa Y; Amanuma H
J Virol; 1995 Dec; 69(12):7606-11. PubMed ID: 7494268
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
Subramanian A; Hegde S; Correll PH; Paulson RF
Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the structure-function relationship of the leukemogenic membrane glycoprotein (GP55) of Friend spleen focus-forming virus (F-SFFV).
Amanuma H; Yugawa T; Watanabe N; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():160-1. PubMed ID: 9209329
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin.
Johnson P; Chung S; Benchimol S
Mol Cell Biol; 1993 Mar; 13(3):1456-63. PubMed ID: 8441390
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
13. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.
Nishigaki K; Thompson D; Hanson C; Yugawa T; Ruscetti S
J Virol; 2001 Sep; 75(17):7893-903. PubMed ID: 11483734
[TBL] [Abstract][Full Text] [Related]
14. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
15. Sequence flexibility in the polytropic env gp70-derived region of the membrane glycoprotein (gp55) of Friend spleen focus-forming virus affects its biological activity.
Yugawa T; Amanuma H
J Virol; 1998 Mar; 72(3):2272-9. PubMed ID: 9499086
[TBL] [Abstract][Full Text] [Related]
16. A mouse erythroleukemia cell line possessing friend spleen focus-forming virus gp55 transgene and temperature-sensitive mutant p53 gene.
Xu X; Yamamura Y; Tsukada T; Yoshida MA; Senda H; Nagayoshi M; Ikeuchi T; Ikawa Y
Jpn J Cancer Res; 1995 Mar; 86(3):284-91. PubMed ID: 7744699
[TBL] [Abstract][Full Text] [Related]
17. Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells.
Aizawa S; Suda Y; Furuta Y; Yagi T; Takeda N; Watanabe N; Nagayoshi M; Ikawa Y
EMBO J; 1990 Jul; 9(7):2107-16. PubMed ID: 2162763
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S
J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978
[TBL] [Abstract][Full Text] [Related]
19. Requirement of the single base insertion at the 3' end of the env-related gene of Friend spleen focus-forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55).
Amanuma H; Watanabe N; Nishi M; Ikawa Y
J Virol; 1989 Nov; 63(11):4824-33. PubMed ID: 2552155
[TBL] [Abstract][Full Text] [Related]
20. Friend erythroleukemia revisited.
Ney PA; D'Andrea AD
Blood; 2000 Dec; 96(12):3675-80. PubMed ID: 11090047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
